Colace and Eyelid injury - a phase IV clinical study of FDA data
Summary:
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Colace?
Colace has active ingredients of docusate . It is used in constipation. Currently, eHealthMe is studying from 40,321 Colace users.
What is Eyelid Injury?
Eyelid injury is found to be associated with 180 drugs and 96 conditions by eHealthMe. Currently, we are studying 167 people who have Eyelid injury.
Do you take Colace and have Eyelid injury?
Check whether Eyelid injury is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Colace side effects by duration, gender and age:
- Colace side effects (40,321 reports)
Eyelid injury treatments and more:
- Eyelid injury (167 reports)
All the drugs that are associated with Eyelid injury:
All the conditions that are associated with Eyelid injury:
How the study uses the data?
The study uses data from the FDA. It is based on docusate (the active ingredients of Colace) and Colace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bextra and Fungal Nail Infection - 15 seconds ago
- Novorapid and Methotrexate drug interaction - 16 seconds ago
- Nevanac and Exelon drug interaction - 22 seconds ago
- Eliquis and Onychoclasis - 25 seconds ago
- Viramune and Nephritis Interstitial - 29 seconds ago
- Inbrija and Tymlos drug interaction - 35 seconds ago
- Vitamin E and Respiratory Rate Increased - 36 seconds ago
- Hydramine and Eye Disorder - 40 seconds ago
- Nuedexta and Restless Leg Syndrome - 41 seconds ago
- Lasix and Melaena - 47 seconds ago